6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazol-3-amine

Catalog No. :
ACGJQH310
CAS No. :
2377608-60-9
Molecular Formula :
C13H17BN2O3
Molecular Weight :
260.10

IUPAC Name:6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazol-3-amine

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazol-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg96%$234.00Login to see priceInquiryInquiry
250mg96%$371.00Login to see priceInquiryInquiry
1g96%$897.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazol-3-amine
IUPAC Name6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]isoxazol-3-amine
MDL No.MFCD16995911
Molecular FormulaC13H17BN2O3
Molecular Weight260.10
SMILESNC1=NOC2=CC(B3OC(C)(C)C(C)(C)O3)=CC=C12
InChI KeyBLCZZUDXADYFSH-UHFFFAOYSA-N
Synonym3-Aminobenzo[d]isoxazole-6-boronic acid pinacol ester;1,2-Benzisoxazol-3-amine, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2377608-60-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGJQH310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACMHYR150 route compound structure diagram
    ACMHYR150177995-39-0 In Stock
  4. Then
  5. ACGJQH310 route product structure diagram
    ACGJQH3102377608-60-9
Inquiry

2. ACGJQH310 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGJQH310 route product structure diagram
    ACGJQH3102377608-60-9
Inquiry

Comments (0)